XML 86 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Earnings (Loss) Per Share (Tables)
12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Reconciliation of the Numerator and Denominator of Basic and Diluted Earnings (Loss) Per Share The following is a reconciliation of the numerator and denominator of basic and diluted earnings (loss) per share for the years ended December 31, 2019, 2018, and 2017:

(In thousands except per share data)

 

Year Ended December 31,

 

Numerator:

 

2019

 

 

2018

 

 

2017

 

Income (loss) from continuing operations attributable to Tivity Health,

   Inc. - numerator for earnings (loss) per share

 

$

(286,821

)

 

$

97,902

 

 

$

61,230

 

Net income from discontinued operations attributable to

   Tivity Health, Inc. - numerator for earnings (loss) per share

 

 

—

 

 

 

901

 

 

 

2,485

 

Net income (loss) attributable to Tivity Health, Inc. - numerator for

   earnings (loss) per share

 

$

(286,821

)

 

$

98,803

 

 

$

63,715

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Shares used for basic income (loss) per share

 

 

46,509

 

 

 

40,078

 

 

 

39,357

 

Effect of dilutive stock options and restricted stock units

   outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Non-qualified stock options

 

 

—

 

 

 

264

 

 

 

436

 

Restricted stock units

 

 

—

 

 

 

299

 

 

 

549

 

Warrants related to Cash Convertible Notes

 

 

—

 

 

 

2,013

 

 

 

1,709

 

Market stock units

 

 

—

 

 

 

419

 

 

 

496

 

Shares used for diluted income (loss) per share (1)

 

 

46,509

 

 

 

43,073

 

 

 

42,547

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share attributable to Tivity Health, Inc. - basic:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(6.17

)

 

$

2.44

 

 

$

1.56

 

Discontinued operations

 

$

—

 

 

$

0.02

 

 

$

0.06

 

Net income (loss) (2)

 

$

(6.17

)

 

$

2.47

 

 

$

1.62

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share attributable to Tivity Health, Inc. -

   diluted: (1)

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(6.17

)

 

$

2.27

 

 

$

1.44

 

Discontinued operations

 

$

—

 

 

$

0.02

 

 

$

0.06

 

Net income (loss)

 

$

(6.17

)

 

$

2.29

 

 

$

1.50

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dilutive securities outstanding not included in the computation of

   earnings (loss) per share because their effect is anti-dilutive:

 

 

 

 

 

 

 

 

 

 

 

 

Non-qualified stock options

 

 

159

 

 

 

56

 

 

 

4

 

Restricted stock units

 

 

681

 

 

 

36

 

 

 

12

 

Restricted stock awards

 

 

102

 

 

 

—

 

 

 

—

 

Performance-based stock units

 

 

15

 

 

 

—

 

 

 

—

 

 

 

(1)

The impact of potentially dilutive securities for the year ended December 31, 2019 was not considered because the impact would be anti-dilutive.

 

(2)

Figures may not add due to rounding.